Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | CA7 | P43166 | 1/20 | 0.61 |
| ▸ | CA9 | Q16790 | 1/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 5/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.53 |
| ▸ | NPC1 | O15118 | 3/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.51 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7454965 | 0.89 | CA1 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL26187321 | 0.89 | AKR1C3 (0.58) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9212298 | 0.88 | CA12 (0.65) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9467809 | 0.87 | CA12 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29547019 | 0.85 | CA12 (0.77) | CA12CA1CA2CA7CA9 | |
| SCHEMBL383873 | 0.85 | CA12 (0.77) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7287255 | 0.82 | CA12 (0.66) | CA12CA1CA2CA7CA9 | |
| SCHEMBL50229 | 0.82 | MAPT (0.64) | HTTMAPTRAB9AALDH1A1AKR1C3 | |
| SCHEMBL29573531 | 0.82 | MAPT (0.64) | HTTMAPTRAB9AALDH1A1AKR1C3 | |
| SCHEMBL165213 | 0.81 | AKR1C3 (0.71) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4093577-A | ESTERIFYING WITH AN UNSATURATED FATTY ACID A RESIN PRODUCED FROM A DIALKYLAMINOBENZOIC ACID OR A CARBOXY-CONTAINING BENZOPHENONE WITH A POLYBASIC ACID AND A POLYHYDRIC ALCOHOL | TOYO INK MANUFACTURING CO., LTD. (JA) | 1978-06-06 | — | — | US | claimed |
| US-6943183-B2 | 5-substituted tetralones as inhibitors of ras farnesyl transferase | PFIZER INC (US) | 2005-09-13 | — | — | US | disclosed |
| US-20040044057-A1 | 5- substituted tetralones as inhibitors of ras farnesyl trransferase | WARNER-LAMBERT COMPANY | 2004-03-04 | — | — | US | disclosed |
| EP-1276725-A2 | 5-SUBSTITUTED TETRALONES AS INHIBITORS OF RAS FARNESYL TRANSFERASE | WARNER-LAMBERT COMPANY (US) | 2003-01-22 | — | — | EP | disclosed |
| WO-2001079180-A2 | 5-SUBSTITUTED TETRALONES AS INHIBITORS OF RAS FARNESYL TRANSFERASE | WARNER-LAMBERT COMPANY (US) | 2001-10-25 | — | — | WO | disclosed |
| EP-0127203-B1 | NEW PHTHALIDE DERIVATIVES, PROCESS FOR PREPARING THE SAME AND RECORDING SYSTEM UTILIZING THE SAME AS COLOURLESS CHROMOGENIC MATERIAL | KANZAKI PAPER MANUFACTURING CO., LTD (JP) | 1989-06-28 | — | — | EP | disclosed |
| US-4093577-A | ESTERIFYING WITH AN UNSATURATED FATTY ACID A RESIN PRODUCED FROM A DIALKYLAMINOBENZOIC ACID OR A CARBOXY-CONTAINING BENZOPHENONE WITH A POLYBASIC ACID AND A POLYHYDRIC ALCOHOL | TOYO INK MANUFACTURING CO., LTD. (JA) | 1978-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040044057-A1 | 5- substituted tetralones as inhibitors of ras farnesyl trransferase | PTAR1, FNTA, GGPS1 | CA12 4815/4885CA1 4225/4885CA2 4227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.